Xing C.

Xing C. currently serves as the Director of Competitive Intelligence at Alnylam Pharmaceuticals since January 2025. Prior to this role, Xing held the position of Director of Strategy and Corporate Development at Merck KGaA from July 2017 to December 2024, where responsibilities included developing a comprehensive five-year corporate strategy and leading strategic projects focused on emerging technologies. Previously, Xing was with PBG Healthcare Consulting, advancing from Project Manager to Director of Consulting, securing multiple clients and coaching project managers. Additionally, Xing organized alumni networking events as VP of Alumni Relationship and contributed to an industry white paper while serving as a Fellow at InSITE. Experience spans various aspects of management consulting in the biopharma and life sciences industry, demonstrating strong analytical and problem-solving skills.